Cellectis S.A. current report, Q3 FY2017

Cellectis S.A. Form 6-K Summary

Business Context and Reporting Period

This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, on August 2, 2017. The filing serves as a report of a material event pursuant to Rule 13a-16 of the Securities Exchange Act of 1934.

Financial Metrics

The provided filing text does not contain specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity within this document.

Material Changes

The filing does not detail specific material changes to financial performance or operations. The document primarily consists of the cover page and an exhibit index referencing a press release dated August 2, 2017.

Guidance, Outlook, and Risks

The text provided does not include management commentary, forward-looking guidance, risk factors, or details regarding contingencies and unusual items. These details are likely contained within the referenced press release (Exhibit 99.1), which is not included in the input text.

Key Facts for Investor Verification

  • Verify the content of the press release dated August 2, 2017 (Exhibit 99.1) to understand the specific event triggering this filing.
  • Confirm the company's current financial status by reviewing the most recent Form 20-F or quarterly reports, as this 6-K contains no financial statements.
  • Note that the registrant files annual reports under Form 20-F.